International multi-stakeholder consensus statement on clinical trial integrity
- PMID: 37161843
- DOI: 10.1111/1471-0528.17451
International multi-stakeholder consensus statement on clinical trial integrity
Abstract
Objective: To prepare a set of statements for randomised clinical trials (RCT) integrity through an international multi-stakeholder consensus.
Methods: The consensus was developed via: multi-country multidisciplinary stakeholder group composition and engagement; evidence synthesis of 55 systematic reviews concerning RCT integrity; anonymised two-round modified Delphi survey with consensus threshold based on the average percentage of majority opinions; and, a final consensus development meeting. Prospective registrations: (https://osf.io/bhncy, https://osf.io/3ursn).
Results: There were 30 stakeholders representing 15 countries from five continents including triallists, ethicists, methodologists, statisticians, consumer representatives, industry representatives, systematic reviewers, funding body panel members, regulatory experts, authors, journal editors, peer-reviewers and advisors for resolving integrity concerns. Delphi survey response rate was 86.7% (26/30 stakeholders). There were 111 statements (73 stakeholder-provided, 46 systematic review-generated, 8 supported by both) in the initial long list, with eight additional statements provided during the consensus rounds. Through consensus the final set consolidated 81 statements (49 stakeholder-provided, 41 systematic review-generated, 9 supported by both). The entire RCT life cycle was covered by the set of statements including general aspects (n = 6), design and approval (n = 11), conduct and monitoring (n = 19), reporting of protocols and findings (n = 20), post-publication concerns (n = 12), and future research and development (n = 13).
Conclusion: Implementation of this multi-stakeholder consensus statement is expected to enhance RCT integrity.
Keywords: randomised controlled trials; research integrity.
© 2023 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Steneck NH. Fostering integrity in research: definitions, current knowledge, and future directions. Sci Eng Ethics. 2006;12(1):53-74.
-
- Resnik DB, Shamoo AE. The Singapore statement on research integrity. Account Res. 2011;18(2):71-5.
-
- Moher D, Bouter L, Kleinert S, Glasziou P, Sham MH, Barbour V, et al. The Hong Kong principles for assessing researchers: fostering research integrity. PLoS Biol. 2020;18(7):e3000737.
-
- Kretser A, Murphy D, Bertuzzi S, Abraham T, Allison DB, Boor KJ, et al. Scientific integrity principles and best practices: recommendations from a scientific integrity consortium. Sci Eng Ethics. 2019;25(2):327-55.
-
- Di Renzo G, Tosto VTV. The Island of research (one rule): do not block the path of enquiry. In: Di Renzo GC, editor. Essential writing, communication and narrative skills for medical scientists before and after the COVID era. Basel: Springer Nature; 2022. p. 1-17.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources